Pathalys Pharma Study PP3003: Investigational Treatment for Secondary Hyperparathyroidism (SHPT) in End-Stage Kidney Disease (ESKD) Patients on Hemodialysis

Valiance Clinical Research combines expertise, agility, and proactive strategies to optimize clinical development and help deliver impactful therapies to patients